The Trump administration says it will not move forward with a Biden proposal that Medicare cover anti-obesity drugs such as Novo Nordisk’s Wegovy and Zepbound from Eli Lilly.
How policy will be impacting the health care sector this week and beyond:
President Trump spared pharmaceuticals from the opening salvo in his campaign to transform the economy through “reciprocal” tariffs; however, the global drug market may still be hit by reverberations from trade wars. The White House listed pharmaceuticals as exempted from the tariffs in Trump’s order signed Wednesday and set to take effect Saturday. Other exempted goods included copper, semiconductors and lumber articles. …
Texas measles outbreak approaches 500 cases
Branch out with a different read:
Democratic attorneys general in 16 states led by New York and Massachusetts sued the Trump administration Friday over the cancellation of millions of dollars in National Institutes of Health (NIH) grants for medical research. In March, the NIH began to terminate millions of dollars in grant funding for previously approved research projects, including projects focused on diversity, equity and inclusion (DEI), LGBTQ health, …
Around the Nation
What We're Reading
What Others are Reading
Here’s what to know about Saturday’s ‘Hands Off!’ anti-Trump protests
A divided Supreme Court sided with the Trump administration by allowing officials to block $65 million in teacher development grants frozen over concerns … Read more
Opinion related to health submitted to The Hill:
Gene Hackman’s final days reveal America’s elder care crisis Read More Details
Finally We wish PressBee provided you with enough information of ( Trump drops Medicare obesity drug proposal )
Also on site :
- San Diego police shoot, kill man inside car after brief confrontation in Grant Hill
- The Duttons Recover From That Shocking Death on the Next '1923'
- 21 Butter Yellow Nail Ideas That Are Perfect for Spring